Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LQDA | Common Stock | Purchase | $1M | +140K | +27.87% | $7.16 | 641K | Dec 14, 2023 | Direct | F1, F2 |
holding | LQDA | Common Stock | 46.6K | Dec 14, 2023 | See footnote | F3 | |||||
holding | LQDA | Common Stock | 1.54M | Dec 14, 2023 | See footnote | F4 |
Id | Content |
---|---|
F1 | Represents shares of Issuer common stock purchased by the Reporting Person pursuant to that certain Common Stock Purchase Agreement, dated as of December 14, 2023, by and among the Issuer and the Reporting Person. |
F2 | Includes 5,384 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
F3 | The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust. |
F4 | The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. |